Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VOLITIONRX LTDVNRX · Entity 8241 | Director · Executive Director | January 24, 2024 | January 26, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VOLITIONRX LTD
Report date January 24, 2024 · Filed January 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,740,207 |
Reported balance
After 2024-01-24 transaction · row 1
1 source rowRow 1 · 2024-01-24 · Grant · Acquired 22,525 · Balance 1,740,207 F1: On September 28, 2023, the reporting person was awarded 53,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 22,525 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 7,509 units, 7,508 units, and 7,508 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. |
| Common StockSEC Table I · non-derivative | IndirectBy The Dill Faulkes Educational Trust Limited | 356,000 |
Reported balance
Holding disclosure · report date 2024-01-24 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 356,000 F2: These shares of common stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. The reporting person serves as the chairman, director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 28, 2023, the reporting person was awarded 53,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 22,525 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 7,509 units, 7,508 units, and 7,508 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
F2: These shares of common stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. The reporting person serves as the chairman, director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2017 Filed Apr 5, 2017 21:19 UTC | VOLITIONRX LTD VNRX · Entity 8241 | OtherWarrant (Right to Buy) · Derivative | 58,034 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001078782-17-000428 · primary_doc.xml · derivative · entry 2 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,034 shares Expires 2017-05-10 Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 21:19 UTC | VOLITIONRX LTD VNRX · Entity 8241 | OtherCommon Stock | 58,034 | $2.60 | $150,888.40 |
DisclosureSEC source: 0001078782-17-000428 · primary_doc.xml · nonDerivative · entry 1 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,351,284 Read SEC document |
| March 30, 2017 Filed Apr 3, 2017 20:37 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000414 · primary_doc.xml · derivative · entry 1 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-03-30 F1 · derivative.exercise_date: A total of 100,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 21:06 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003867 · primary_doc.xml · derivative · entry 3 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 21:06 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Tax withholdingCommon Stock | 3,379 | $4.44 | $15,002.76 |
DisclosureSEC source: 0001078782-16-003867 · primary_doc.xml · nonDerivative · entry 2 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,293,250 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 21:06 UTC | VOLITIONRX LTD VNRX · Entity 8241 | Exercise / conversionCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001078782-16-003867 · primary_doc.xml · nonDerivative · entry 1 Faulkes Martin Charles · CIK 0001577872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,296,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.